Owens & Minor Inc
NYSE:OMI
Owens & Minor Inc
NYSE:OMI
Price:
2.4
USD
Market Closed
Market Cap:
$185.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Owens & Minor Inc
NYSE:OMI
|
US |
|
American Tower Corp
NYSE:AMT
|
US |
|
Dentsu Group Inc
TSE:4324
|
JP |
Relative Value
There is not enough data to reliably calculate the relative value of OMI.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OMI
Relative Value
Base Case
Not Available
Multiples Across Competitors
OMI Competitors Multiples
Owens & Minor Inc Competitors
Owens & Minor Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Owens & Minor Inc
NYSE:OMI
|
185.5m USD | 0 | -0.1 | 4.4 | 9.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
108.2B USD | 0.3 | 24.9 | 17.5 | 19.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
63.9B USD | 0.2 | 39.3 | 13.9 | 17.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.2B USD | 0.2 | 39 | 13.8 | 17.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
49.9B USD | 0.2 | 30 | 14.5 | 18.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.5B AUD | 2.6 | 33.1 | 24.6 | 24.6 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61.5B CNY | 0.2 | 10.9 | 14.9 | 14.9 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.9B CNY | 1.4 | 16.2 | 12.5 | 12.5 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.7 | 21.6 | 10.5 | 14.8 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
62.7B HKD | 0.1 | 8.1 | 1.4 | 1.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
